ResearcherErasmus MCActive in the last 2 years
Mohammad Hosein Aziz
Matched on ORCID iD 0000-0002-2441-3606; OpenAlex author ID A5075930663. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper
Papers 6
- Overexpression of the adhesion signaling pathway is linked to short-term survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2023.11.001↗
- Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associated With Poor Survival: A Retrospective, M… First author DOI 10.1097/sla.0000000000005865↗
- Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer: A Vicious Cycle. Co-author DOI 10.1097/mpa.0000000000002128↗
- High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.827755↗
- Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.615691↗
- The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilir… Co-author DOI 10.1097/sla.0000000000002660↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Casper H.J. van Eijck · 6 shared papers, 2019–2024 · strength 1.06
- Paper Overexpression of the adhesion signaling pathway is linked to short-term survival in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.11.001↗
- Paper Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer: A Vicious Cycle. DOI 10.1097/mpa.0000000000002128↗
- Paper Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associate… DOI 10.1097/sla.0000000000005865↗
- Dana A. M. Mustafa · 3 shared papers, 2022–2024 · strength 0.66
- Paper Overexpression of the adhesion signaling pathway is linked to short-term survival in pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.11.001↗
- Paper Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer: A Vicious Cycle. DOI 10.1097/mpa.0000000000002128↗
- Paper High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal… DOI 10.3389/fonc.2022.827755↗
- Bas Groot Koerkamp · 3 shared papers, 2019–2023 · strength 0.39
- Paper Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associate… DOI 10.1097/sla.0000000000005865↗
- Paper High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal… DOI 10.3389/fonc.2022.827755↗
- Paper The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer a… DOI 10.1097/sla.0000000000002660↗
- J. Sven D. Mieog · 3 shared papers, 2019–2023 · strength 0.39
- Paper Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associate… DOI 10.1097/sla.0000000000005865↗
- Paper High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal… DOI 10.3389/fonc.2022.827755↗
- Paper The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer a… DOI 10.1097/sla.0000000000002660↗
- Kostandinos Sideras · 3 shared papers, 2019–2022 · strength 0.35
- Paper Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic … DOI 10.3389/fonc.2021.615691↗
- Paper High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal… DOI 10.3389/fonc.2022.827755↗
- Paper The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer a… DOI 10.1097/sla.0000000000002660↗
- Bert A. Bonsing · 2 shared papers, 2019–2023 · strength 0.26
- Paper Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associate… DOI 10.1097/sla.0000000000005865↗
- Paper The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer a… DOI 10.1097/sla.0000000000002660↗
- Mustafa Suker · 2 shared papers, 2019–2022 · strength 0.21
- Paper High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal… DOI 10.3389/fonc.2022.827755↗
- Paper The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer a… DOI 10.1097/sla.0000000000002660↗
- Nynke Michiels · 1 shared paper, 2023 · strength 0.18
- Freek R. van ‘t Land · 1 shared paper, 2023 · strength 0.18
- Marjolein Y.V. Homs · 1 shared paper, 2023 · strength 0.18
- Emma E. Geerdes · 1 shared paper, 2021 · strength 0.14
- Jaap Kwekkeboom · 1 shared paper, 2021 · strength 0.14
- Marco J. Bruno · 1 shared paper, 2021 · strength 0.14
- Claudia J. Lucassen · 1 shared paper, 2022 · strength 0.13
- Jesse V. Groen · 1 shared paper, 2022 · strength 0.13
- Jelle C. van Dongen · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.